Upstream Bio Inc (UPB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | |
| Cash Flows From Operating Activities | |
| Net Income | -8,704 |
| Depreciation Amortization | -966 |
| Accounts receivable | 147 |
| Accounts payable and accrued liabilities | -479 |
| Other Working Capital | -277 |
| Other Operating Activity | -11,537 |
| Operating Cash Flow | $-21,816 |
| Cash Flows From Investing Activities | |
| Change In Deposits | -77,456 |
| PPE Investments | -144 |
| Investing Cash Flow | $-77,600 |
| Cash Flows From Financing Activities | |
| Common Stock Issued | 118 |
| Other Financing Activity | 129,565 |
| Financing Cash Flow | $129,683 |
| Beginning Cash Position | 17,051 |
| End Cash Position | 47,318 |
| Net Cash Flow | $30,267 |
| Free Cash Flow | |
| Operating Cash Flow | -21,816 |
| Capital Expenditure | -144 |
| Free Cash Flow | -21,960 |